Skip to main content

Nebula Research & Development LLC

SEC CIK
0001792635
Latest filing
May 15, 2026

MCRB holding history

Seres Therapeutics, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MCRB overviewAll 13F holders of MCRBFull Q1 2026 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2023
Holdings of MCRB by Nebula Research & Development LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−11,893−100.0%Sold outHolders
Q1 202311,893$67.4K0.1%–No prior filingHolders